Compare NXST & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NXST | ICLR |
|---|---|---|
| Founded | 1996 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 7.1B |
| IPO Year | 2002 | 2001 |
| Metric | NXST | ICLR |
|---|---|---|
| Price | $246.67 | $106.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $220.33 | $194.38 |
| AVG Volume (30 Days) | 338.2K | ★ 3.4M |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.20% | N/A |
| EPS Growth | ★ 122.10 | N/A |
| EPS | ★ 8.57 | N/A |
| Revenue | ★ $5,407,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.31 | N/A |
| P/E Ratio | $27.13 | ★ $12.91 |
| Revenue Growth | ★ 9.61 | N/A |
| 52 Week Low | $141.66 | $66.57 |
| 52 Week High | $254.30 | $211.00 |
| Indicator | NXST | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 68.29 | 35.01 |
| Support Level | $182.70 | $66.57 |
| Resistance Level | $254.30 | $189.62 |
| Average True Range (ATR) | 9.97 | 8.78 |
| MACD | 0.24 | -0.42 |
| Stochastic Oscillator | 80.18 | 45.30 |
Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Pending approval, Nexstar's merger with Tegna would bring Nexstar's station total to 259 in 133 markets, reaching 80% of the US population. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.